Nadezhda Zinina

Nadezhda Zinina

Auto-generated profile, based on publicly available information

Nadezhda Zinina

Research Institute for Biological Safety Problems, Gvardeyskiy, Kazakhstan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
DBDina Bugybayeva
Dina Bugybayeva
SRSholpan Ryskeldinova
Sholpan Ryskeldinova
NZNadezhda Zinina
Nadezhda Zinina
MSMakhpal Sarmykova
Makhpal Sarmykova
NANurika Narynbekovna Assanzhanova
Nurika Narynbekovna Assanzhanova
KTKaissar Tabynov
Kaissar Tabynov
In this paper, we first used recombinant influenza viral vector (rIVV) subtype H5N1 expressing from the open reading frame of NS1 80 and NS1 124 amino acids of Brucella outer membrane proteins (Omp) 16 and 19, ribosomal L7/L12, and Cu‐Zn superoxide dismutase (SOD) proteins to develop a human brucellosis vaccine. We made 18 combinations of IVVs in mono‐, bi‐, and tetravalent vaccine formulations and tested them on mice to select the safest and most effective vaccine samples. Then, the most effective vaccine candidates were further tested on guinea pigs. Safety of the rIVV‐based vaccine candidate was evaluated by a mouse weight‐gain test. Mice and guinea pigs were challenged with the virulent strain B. melitensis 16M. The protective effect of the rIVV‐based vaccine candidate was assessed by quantitation of Brucella colonization in tissues and organs of challenged animals. All vaccine formulations were safe in mice. Tested vaccine formulations, as well as the commercial B. melitensis Rev.1 vaccine, have been found to protect mice from B. melitensis 16M infection within the range of 1.6 to 2.97 log10 units (P < 0.05). Tetravalent vaccine formulations from the position of NS1 80 amino acids (0.2 ± 0.4), as well as the commercial B. melitensis Rev.1 vaccine (1.2 ± 2.6), have been found to protect guinea pigs from B. melitensis 16M infection at a significant level (P < 0.05). Thus, tetravalent vaccine formulation Flu‐NS1‐80‐Omp16+Flu‐NS1‐80‐L7/L12+Flu‐NS1‐80‐Omp19+Flu‐NS1‐80‐SOD was chosen as a potential vaccine candidate for further development of an effective human vaccine against brucellosis. These results show a promising future for the development of a safe human vaccine against brucellosis based on rIVVs.

28 June 2026 in The Iraqi Journal of Veterinary Medicine
Verified
Journal Article
Open access
PDF file
ATAlinur Toleukhan
Alinur Toleukhan
BYBolat Yespembetov
Bolat Yespembetov
ZSZhumagul Slyambekova
Zhumagul Slyambekova
AZArman Zhylkaidar
Arman Zhylkaidar
BYBekzat Yerzhigit
Bekzat Yerzhigit
AAAkbope Abdykalyk
Akbope Abdykalyk
Non-typhoidal Salmonella enterica continues to be a significant pathogen of global relevance. However, there is limited available comparative experimental data on the virulence of S. enterica strains that are isolated from poultry and circulating in Central Asia. This study aimed to investigate the virulence of four poultry-derived S. enterica isolates recovered in Kazakhstan using a standardized murine model of systemic infection. Outbred mice were inoculated intraperitoneally with graded bacterial doses ranging from 103 to 106 CFU and the pathogenicity was assessed by determining the median infectious dose (ID50) and median lethal dose (LD50) according to the Reed-Muench method. Systemic infection was confirmed by bacteriological re-isolation and real-time PCR. Mortality occurred primarily within 18-72 h post-inoculation and followed a clear dose-dependent pattern. Two S. enterica serovar Infantis strains showed relatively low LD50 (3.16 × 105 CFU) compared to the other isolates (1.78 × 106 CFU). This indicates relatively high virulence potential of the two S. Infantis strains compared to the others. Similar results were seen in the case of the ID50, where the same strains showed relatively high infectivity potential compared to the others. It is noteworthy that the systemic infection was seen with doses that were not lethal to the host, indicating some dissociation between virulence and infectivity potential‎‎‎.

25 May 2023 in Ġylym ža̋ne bìlìm
Verified
Journal Article
Closed access
ТКТилеуханов К. К.
Тилеуханов К. К.
ЕАЕспембетов Б. А
Еспембетов Б. А
ЗНЗинина Н. Н
Зинина Н. Н
КЖКаукарбаева М. Ж
Каукарбаева М. Ж
ШЕШалғынбек Е.ж.
Шалғынбек Е.ж.

28 July 2026 in Applied Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
ATAlinur Toleukhan
Alinur Toleukhan
AAAkbope Abdykalyk
Akbope Abdykalyk
AAAktoty Anarbekova
Aktoty Anarbekova
AAAzamat Abdimukhtar
Azamat Abdimukhtar
BYBekzat Yerzhigit
Bekzat Yerzhigit
BYBolat Yespembetov
Bolat Yespembetov
Salmonella enterica bacteriophages are increasingly studied for bacterial biocontrol and applied microbiology. However, reliable downstream characterization depends strongly on how the phage material is purified and concentrated. This study compared five preparation strategies for a Salmonella bacteriophage: sucrose density gradient centrifugation, cesium chloride gradient centrifugation, ultrafiltration followed by lyophilization, ultrafiltration followed by ammonium sulfate precipitation, and ultrafiltration followed by trichloroacetic acid precipitation. The preparations were assessed for infectious phage recovery, total protein concentration, SDS-PAGE protein profiles, an exploratory molecular weight-based comparison with a reference phage dataset, and targeted real-time PCR screening for selected virulence-associated determinants. Ultrafiltration followed by ammonium sulfate precipitation gave the highest infectious phage recovery among the infectivity-preserving workflows and produced a consistent eight-band SDS-PAGE profile. Trichloroacetic acid precipitation produced a similar banding pattern but was considered mainly a protein precipitation method because of its denaturing effect. Cesium chloride gradient centrifugation gave the most complex SDS-PAGE profile, while ultrafiltration followed by lyophilization gave the least resolved one. Several bands fell within the molecular-mass ranges reported for proteins of related Salmonella phages, but matching by molecular mass alone cannot identify the proteins, which would require LC-MS/MS. Targeted real-time PCR did not detect sopE , sspH1 , sseI , or sopE2 . Under the conditions tested, ultrafiltration followed by ammonium sulfate precipitation gave the highest infectious recovery and a consistent SDS-PAGE pattern; these results describe how the workflows behaved here rather than showing that one method is generally superior. Key points: • Five workflows were compared for Salmonella phage purification. • Ammonium sulfate precipitation gave the highest infectious recovery. • Selected virulence-associated genes were not detected by qPCR.

16 September 2024 in Biosafety and Biotechnology
Verified
Journal Article
Open access
PDF file
NZN. N. Zinina
N. N. Zinina
BYBolat Yespembetov
Bolat Yespembetov
NSNazym Syrym
Nazym Syrym
SAS. E. Alpysbaeva
S. E. Alpysbaeva
MSM. K. Sarmykova
M. K. Sarmykova
ЕСЕ. Б. Серикбай
Е. Б. Серикбай
When testing anti-brucellosis vaccines, an important role is played by studying the infecting dose of control strains. To restore the virulent properties of the control strains Brucella melitensis 16 M and Brucella abortus 544, it is necessary to carry out multiple successive passages in different doses (starting from 1,000,000 colony-forming units, CFU/cm3 to 5 CFU/cm3), through the body of sensitive laboratory animals. In this case, for experimental work, we took 54 heads of guinea pigs (males) weighing 350-380 g, from which we created 9 groups of 6 heads each. The article reflects the progress and results of research into determining the minimum fixing infectious dose of the control reference strains Brucella melitensis 16 M and Brucella abortus 544.Based on the results of the studies, the minimum infectious dose (5 CFU) of Brucella after the ninth passage, which causes the generalized form of brucellosis, was determined. Spent virulent fixing doses (5 CFU/cm3) strains of Brucella melitensis 16 M and Brucella abortus 544 can be used for control infection when setting up various experiments to determine and evaluate the immunogenicity of anti-brucellosis vaccines and chemoprophylaxis.

16 September 2024 in Biosafety and Biotechnology
Verified
Journal Article
Open access
PDF file
NSNazym Syrym
Nazym Syrym
BEB. A. Espembetov
B. A. Espembetov
AAA. M. Anarbekova
A. M. Anarbekova
NZN. N. Zinina
N. N. Zinina
SAS. E. Alpysbaуeva
S. E. Alpysbaуeva
AMA. D. Maulenbay
A. D. Maulenbay
Bacterial infections caused by multidrug-resistant (MDR) strains are among the most dangerous threats to global public health. The highest number of resistance cases is detected among the so-called ESKAPE pathogens (from the initials of Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.). These bacteria cause life-threatening nosocomial infections, especially in individuals with weakened immune systems and chronic diseases. The article discusses the rationale for phage therapy, clinical problems, and proposes phage therapy as an effective means against ESKAPE pathogens. It characterizes some of their biological properties (effect of high temperature, resistance to chloroform exposure, and the impact of pH changes on bacteriophage activity). High temperature was studied as a physical factor, and chloroform exposure as a chemical factor affecting bacteriophages. The study found that heating phages for 30 minutes at 60°C did not affect their activity. They maintained activity within a pH range of 7.0 to 7.5 and were resistant to chloroform exposure for 40 minutes. It should be noted that the alkaline environment of the buffer solution slightly affected the activity of the studied bacteriophages, while the acidic environment had a more significant impact on reducing their infectivity.